LANESIA CEPHUS: Open Payments
NPI 1598120719 · HARVEY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 10 payments from 6 companies in 2025. Trend: 2023 $230 · 2024 $108 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $84 |
| ABBVIE INC. | 2 | $45 |
| Exact Sciences Corporation | 2 | $34 |
| Lilly USA, LLC | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Wegovy, VRAYLAR, MOUNJARO, The Cologuard Plus Collection Kit, GVOKE HYPOPEN, BEXSERO, Cologuard Collection Kit.
Industry payments across IL — which companies pay providers there.
